SpectraBase Spectrum ID |
DmlznNtNdqq |
Name |
Thiobutabarbitone 2ME |
Classification |
Pharmaceutical drug derivative |
Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
DEA Citation |
21 CFR §1308.13 (c) (3) |
DEA Controlled Substance Form |
Any compound, mixture or preparation |
DEA Controlled Substance Name |
Barbituric acid derivatives |
DEA Controlled Substance Type |
Salts, isomers, derivatives and salts of isomers and derivatives |
DEA Controlled Substances Code Number |
2100 |
DEA Schedule |
Schedule III |
DEA Section |
Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system |
Exact Mass |
256.124549064 u |
Formula |
C12H20N2O2S |
InChI |
InChI=1S/C12H20N2O2S/c1-6-8(3)12(7-2)9(15)13(4)11(17)14(5)10(12)16/h8H,6-7H2,1-5H3 |
InChIKey |
QJMYCVKZAODGMI-UHFFFAOYSA-N |
Ionization Type |
Electron Ionization (EI) |
Molecular Weight |
256.364 g/mol |
Nominal Mass |
256 u |
Quality |
980 |
Retention Index |
1678 |
SMILES |
C1(C(N(C(N(C1=O)C)=S)C)=O)(C(CC)C)CC |
SPLASH |
splash10-0udr-9550000000-7747f260bb7c068cb35a |
Source of Spectrum |
DigiLab GmbH (C) 2024 |
Synonyms |
5-(butan-2-yl)-5-ethyl-1,3-dimethyl-2-thioxo-1,3-diazinane-4,6-dione |
Technique |
GC/MS |
Wiley ID |
DD2024_005318 |